Nasdaq: $30.02 (+4.13) | AIM: £4.27 (+0.57)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
監管信息公告, 腫瘤學 / 免疫學 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility